Prosecution Insights
Last updated: July 17, 2026
Application No. 17/999,905

COSMETIC COMPOSITION

Non-Final OA §103§DOUBLEPATENT
Filed
Nov 25, 2022
Priority
Jun 01, 2020 — JP 2020-095661 +1 more
Examiner
BABSON, NICOLE PLOURDE
Art Unit
1619
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Kao Corporation
OA Round
3 (Non-Final)
47%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
79%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allowance Rate
245 granted / 526 resolved
-13.4% vs TC avg
Strong +32% interview lift
Without
With
+32.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
54 currently pending
Career history
585
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
67.1%
+27.1% vs TC avg
§102
12.4%
-27.6% vs TC avg
§112
3.4%
-36.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 526 resolved cases

Office Action

§103 §DOUBLEPATENT
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION The Applicant’s reply filed on 10/27/25 is acknowledged. Claims 1-21 are pending. Claims 3, 12-14, 16 and 17 have been withdrawn. Claims 1, 9 and 15 have been amended. Claims 18-21 are new. Claims 1, 2, 4-11, 15 and 18-21 are under consideration to the extent that the cosmetic composition comprises Species (A): trimethylsiloxysilicate; and Species (C): (Bisisobutyl PEG-15/amodimethicone) copolymer (SS-3588, Component C). Objections Withdrawn The objections to the Drawings withdrawn in view of the amended Drawings. The objections to the Specification are withdrawn in view of the amendments. Rejections Maintained and New Grounds of Rejections Terminal Disclaimer The terminal disclaimer filed on 10/27/25 disclaiming the terminal portion of any patent granted on this application which would extend beyond the expiration date of 12,064,505; 12,144,883; and 12,194,127 has been reviewed and is accepted. The terminal disclaimer has been recorded. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1, 2, 4-11, 15, 18 and 19 are rejected under 35 U.S.C. 103 as being unpatentable over Terada (JP 2009/298743-A) in view of Reich et al. (US 6,287,546; 2001). Terada teaches a hair detergent having an appropriate viscosity, a good foaming property with a fine foam quality having a good slidability on washing the hair, a smooth feeling on rinsing and also a good low temperature stability (e.g. abstract). Terada discloses the inclusion of two or more kinds of silicones may be used in combination, including the high-molecular weight organopolysiloxane KF-96H-1,000,000 (i.e. component (B)) and an amino-modified silicone including SS-3588 (i.e. component (C) bisisobutyl PEG-15/amodimethicone as evidenced by Applicant’s election and Specification) (e.g. pages 7-8). Terada further teaches the inclusion of an oil agent, including hydrocarbons and higher alcohols, and a viscosity modifier, including ethanol and benzyl alcohol (i.e. liquid organic solvents) (e.g. page 9). Terada does not teach the inclusion of a silicone film-forming agent (A). This is made up for by the teachings of Reich et al. Reich et al. teach improved stabilized shampoo compositions containing siloxysilicate materials (e.g. abstract). Reich et al. teach that the siloxysilicates material is trimethylsiloxysilicate (e.g. column 5, lines 13-25; Claim 15). Reich et al. teach that it is an object of the invention to provide shampoo compositions which contain MQ resins and to retain the stability of the compositions which can be formulated with a variety of MQ resins depending on the types of properties desired, for example, increased shine, conditioning effects, reduced combing force, curl retention, volume and/or better manageability (e.g. column 1, lines 39-56). Regarding Claims 1, 2, 4-6, and 15, it would have been obvious to one of ordinary skill in the art to combine the elements as claimed by known methods with no change in their respective functions, and the combination yielding nothing more than predictable results. One of ordinary skill in the art would have predicted success as both of the compositions are useful as hair shampoos and one of ordinary skill would have been motivated in order to provide the benefits of slidability on washing the hair, a smooth feeling on rinsing, increased shine, conditioning effects, reduced combing force, curl retention, volume and/or better manageability, as taught by Terada and Reich et al. In addition, "It is prima facie obvious to combine two compositions each of which is taught by the prior art to be useful for the same purpose, in order to form a third composition to be used for the very same purpose.... [T]he idea of combining them flows logically from their having been individually taught in the prior art." In re Kerkhoven, 626 F.2d 846, 850, 205 USPQ 1069, 1072 (CCPA 1980). Regarding Claims 7 and 8, Terada teaches 0.01-10% of the two or more silicones (i.e. (B)+(C)) (e.g. page 8). Assuming a 50/50 split for the two silicones results in 0.005-5% (B) and 0.005-5% (C). Reich et al. teach 0.1-15 w% of the siloxysilicates (A) (e.g. Claim 1). This results in a ratio of C/(A+B+C) of (0.005-5)/(0.11-25), or approximately 0.02-50 wt%, which overlaps the claimed ratio and total. In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990) (MPEP 2144.05.I). Regarding Claim 9, Terada further teaches the inclusion of titanium oxide, which as evidenced by [0091] is a functional powder (e.g. page 9). Regarding Claims 10 and 11, the limitations are directed to an intended use and do not structurally further limit claim 1. A recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. In the instant case the composition is taught by Terada and Reich et al. In addition, both Terada and Reich et al. teach that the compositions are for hair and may further comprise dyes (e.g. Terada page 9, and Reich Claim 22). Regarding Claims 18 and 19, Terada teaches that the oil agent may be liquid isoparaffin and the viscosity modifier may be ethanol and benzyl alcohol (e.g. page 9). Claims 20 and 21 are rejected under 35 U.S.C. 103 as being unpatentable over Terada (JP 2009/298743-A) in view of Reich et al. (US 6,287,546; 2001) as applied to claims 1, 2, 4-11, 15, 18 and 19 above, and further in view of Wells et al. (US 5,883,058; 1999). Regarding Claims 1, 2, 4-11, 15, 18 and 19 the teachings of Terada and Reich et al. are described supra. Terada further teaches the inclusion of an oil agent, including hydrocarbons and higher alcohols, and a viscosity modifier, including ethanol and benzyl alcohol (i.e. liquid organic solvents) (e.g. page 9), but does not teach the inclusion of isododecane. This is made up for by the teachings of Wells et al. Wells et al. teach hair shampoo compositions which have improved cleansing, lathering, and styling benefits comprising an alkyl glyceryl ether sulfonate surfactant, a hair styling polymer, a non-polar volatile solvent, and water (e.g. abstract). Wells et al. teach that styling agents, such as styling polymers, cannot be readily incorporated into conventional shampoos without suppressing the lathering and cleansing ability of the shampoos, or the ultimate deposition and performance of the styling polymer (e.g. column 1, line 53-60). Wells et al. teach that upon deposition of the polymer and solvent mixture onto the hair, the solvent is volatilized leaving only the styling polymer on the hair, thus providing the maximum styling benefits (e.g. column 7, lines 26-29). Wells et al. teach that the non-polar solvent is preferably isododecane (e.g. column 7, lines 34-59; Examples). Regarding Claims 20 and 21, it would have been obvious to one of ordinary skill in the art to combine the elements as claimed by known methods with no change in their respective functions, and the combination yielding nothing more than predictable results. One of ordinary skill in the art would have predicted success as all of Terada, Reich, and Wells are useful as hair shampoos and one of ordinary skill would have been motivated in order to provide the benefits of improved cleansing, lathering, and styling benefits, as taught by Wells et al. In addition, "It is prima facie obvious to combine two compositions each of which is taught by the prior art to be useful for the same purpose, in order to form a third composition to be used for the very same purpose.... [T]he idea of combining them flows logically from their having been individually taught in the prior art." In re Kerkhoven, 626 F.2d 846, 850, 205 USPQ 1069, 1072 (CCPA 1980). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP §§ 706.02(l)(1) - 706.02(l)(3) for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claims 1, 2, 4-11, 15 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claim 6 of copending Application No. 18/713,556 in view of Terada (JP 2009/298743-A). Although the claims at issue are not identical, they are not patentably distinct from each other because both the instant and copending claim require, a cosmetic composition comprising (A) a silicone film-forming agent, and (B) a high-molecular-weight organopolysiloxane (i.e. having a degree of polymerization of 100 or more). Copending ‘556 does not claim the inclusion of component (C) an organopolysiloxane having a cationic group, other than the component (A) and the component (B). This is made up for by the teachings of Terada. Terada discloses the inclusion of two or more kinds of silicones may be used in combination, including the high-molecular weight organopolysiloxane KF-96H-1,000,000 (i.e. component (B)) and an amino-modified silicone including SS-3588 (i.e. component (C) bisisobutyl PEG-15/amodimethicone as evidenced by Applicant’s election and Specification) (e.g. pages 7-8). It would have been obvious to one of ordinary skill in the art to combine the elements as claimed by known methods with no change in their respective functions, and the combination yielding nothing more than predictable results. "It is prima facie obvious to combine two compositions each of which is taught by the prior art to be useful for the same purpose, in order to form a third composition to be used for the very same purpose.... [T]he idea of combining them flows logically from their having been individually taught in the prior art." In re Kerkhoven, 626 F.2d 846, 850, 205 USPQ 1069, 1072 (CCPA 1980). This is a provisional nonstatutory double patenting rejection. Claims 1, 2, 4-11 and 15 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claim 10 of copending Application No. 18/713,537 in view of Terada (JP 2009/298743-A). Although the claims at issue are not identical, they are not patentably distinct from each other because both the instant and copending claim require, a cosmetic composition comprising (A) a silicone film-forming agent, and component (B) (C in the instant claims) an organopolysiloxane having a cationic group, other than the component (A), Copending ‘537 does not claim the inclusion of (B) a high-molecular-weight organopolysiloxane. This is made up for by the teachings of Terada. Terada discloses the inclusion of two or more kinds of silicones may be used in combination, including the high-molecular weight organopolysiloxane KF-96H-1,000,000 (i.e. component (B)) and an amino-modified silicone including SS-3588 (i.e. component (C) bisisobutyl PEG-15/amodimethicone as evidenced by Applicant’s election and Specification) (e.g. pages 7-8). It would have been obvious to one of ordinary skill in the art to combine the elements as claimed by known methods with no change in their respective functions, and the combination yielding nothing more than predictable results. "It is prima facie obvious to combine two compositions each of which is taught by the prior art to be useful for the same purpose, in order to form a third composition to be used for the very same purpose.... [T]he idea of combining them flows logically from their having been individually taught in the prior art." In re Kerkhoven, 626 F.2d 846, 850, 205 USPQ 1069, 1072 (CCPA 1980). This is a provisional nonstatutory double patenting rejection. Response to Arguments and Declaration Applicant's arguments filed 10/27/25 have been fully considered but they are not persuasive. Applicant argues on page 11 that there is nothing in the cited references which would suggest the addition of an organic solvent. This is not found persuasive. As described supra, Terada further teaches the inclusion of an oil agent, including hydrocarbons and higher alcohols, and a viscosity modifier, including ethanol and benzyl alcohol (i.e. liquid organic solvents) (e.g. page 9). Applicant further argues, beginning on page 11 that, as explained in the Declaration of Maekawa, additional Comparative Examples 1 and 2 in which the composition does not contain any (A), a silicone film-forming agent, were prepared and evaluated as described in the above-identified application, and the shampoo resistance for the additional comparative examples was evaluated. The Additional Comparative Examples are inferior in terms of rubfastness (difficulty of color transfer) and shampooing resistance (difficulty of color discoloration by shampooing). This is not found persuasive. The claims are much broader than the tested compositions, both in terms of ingredients and amounts thereof. It is unclear if the same effect would be seen for all concentrations and structures within the scope of the claims. Whether the unexpected results are the result of unexpectedly improved results or a property not taught by the prior art, the “objective evidence of nonobviousness must be commensurate in scope with the claims which the evidence is offered to support.” In other words, the showing of unexpected results must be reviewed to see if the results occur over the entire claimed range. In re Clemens, 622 F.2d 1029, 1036, 206 USPQ 289, 296 (CCPA 1980). Accordingly, the rejections are maintained. Conclusion No claim is allowed. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICOLE PLOURDE BABSON whose telephone number is (571)272-3055. The examiner can normally be reached M-Th 8-4:30; F 8-12:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Blanchard can be reached on 571-272-0827. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NICOLE P BABSON/ Primary Examiner, Art Unit 1619
Read full office action

Prosecution Timeline

Nov 25, 2022
Application Filed
Jun 26, 2025
Non-Final Rejection mailed — §103, §DOUBLEPATENT
Oct 27, 2025
Response Filed
Dec 29, 2025
Final Rejection mailed — §103, §DOUBLEPATENT
May 26, 2026
Request for Continued Examination
May 27, 2026
Response after Non-Final Action
Jul 14, 2026
Non-Final Rejection mailed — §103, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678393
MULTI-LAYER TYPE MAKEUP PROTECTION COSMETIC
4y 10m to grant Granted Jul 14, 2026
Patent 12678385
NAIL POLISH GLUE AND PREPARATION METHOD AND APPLICATION THEREOF
3y 3m to grant Granted Jul 14, 2026
Patent 12653766
COMPOSITION COMPRISING A COMBINATION CONSISTING OF MAGNOLOL AND HONOKIOL, USE OF THE COMPOSITION, METHOD OF MANUFACTURING THE COMPOSITION, AND COSMETIC PRODUCTS COMPRISING THE COMPOSITION AND METHOD OF MANUFACTURING THEREOF
2y 9m to grant Granted Jun 16, 2026
Patent 12649831
PLASTICISED SUPERPOROUS HYDROGEL
4y 2m to grant Granted Jun 09, 2026
Patent 12611489
METHODS FOR GENERATING SURFACE COATINGS VIA SELF-ASSEMBLY OF SILK FIBROIN AND SILK FIBROIN-LIKE MACROMOLECULES
4y 1m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
47%
Grant Probability
79%
With Interview (+32.5%)
3y 6m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 526 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month